A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer

Journal of Medical Imaging and Radiation Oncology

Volumn 57, Issue 1, 2013, Pages 81-88

  Ilic, Dragan ^a   Hindson, Ben ^a,b   Duchesne, Gillian ^a,c,d   Millar, Jeremy L ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

erectile dysfunction; prostate cancer; radiotherapy; randomised controlled trial; sildenafil citrate

Indexed keywords

PLACEBO; SILDENAFIL;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DYSPEPSIA; ERECTILE DYSFUNCTION; EVENING DOSAGE; FLUSHING; FOLLOW UP; HEMATEMESIS; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MALE; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SHOULDER PAIN;

AGED; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLACEBO EFFECT; PROSTATIC NEOPLASMS; PURINES; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84873374546     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2012.02461.x     Document Type: Article

References (52)

1. Mulhall J,. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol 2009; 181: 462-471.
2. Taira V, Merrick G, Galbreath R, et al. Erectile function durability following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75: 639-648.
3. Pinkawa M, Gagel B, Piroth M, et al. Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009; 55: 227-236.
4. Schover L, Fouladi R, Warneke C, et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 2002; 95: 2397-2407.
5. Steginga S, Occhipinti S, Dunn J, Gardiner R, Heathcote P, Yaxley J,. The supportive care needs of men with prostate cancer (2000). Psychooncology 2001; 10: 66-75.
6. Penson D, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21: 1147-1154.
7. Sanda M, Dunn R, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261.
8. Wilt T, MacDonald R, Rutks I, Shamliyan T, Taylor B, Kane R,. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-448.
9. Thompson I, Thrasher J, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177: 2106-2131.
10. Knight S, Latini D,. Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences. Cancer J 2009; 15: 41-44.
11. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71.
12. Robinson J, Moritz S, Fung T,. Meta-analysis of rates of erectile function after treatment of localised prostate carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 1063-1068.
13. Raina R, Agarwal A, Ausmundson S, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 2006; 18: 77-81.
14. Tsui G, Gillan C, Catton C, Crook J,. Posttreatment complications of early-stage prostate cancer patients: brachytherapy versus three-dimensional conformal radiation therapy. Cancer J 2005; 11: 122-132.
15. Cesaretti J, Kao J, Stone N, Stock R,. Effect of low dose-rate brachytherapy on the sexual health of men with optimal sexual function before treatment at ≥7 years of follow-up. BJU Int 2007; 100: 362-367.
16. Alemozaffar M, Regan M, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA 2011; 306: 1205-1214.
17. Incrocci L,. Sexual function after external-beam radiotherapy for prostate cancer: what do we know? Crit Rev Oncol Hematol 2006; 57: 165-173.
18. Miles C, Candy B, Jones L, Williams R, Tookman A, King M,. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007; (4): CD005540. DOI: 10.1002/14651858.CD14005540.pub14651852.
19. Melnik T, Soares B, Nasello A,. Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev 2008; (4): CD004825. DOI: 10.1002/14651858.CD14004825.pub14651852.
20. Urciuoli R, Cantisani T, Carlini M, Giuglietti M, Botti F,. Prostaglandin E1 for treatment of erectile dysfunction. Cochrane Database Syst Rev 2004; (2): CD001784. DOI: 10.1002/14651858.CD14001784.pub14651852.
21. McVary K,. Clinical practice. Erectile dysfunction. N Engl J Med 2007; 357: 2472-2481.
22. Mulhall J, Morgentaler A,. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007; 4: 538-543.
23. Montorsi F, McCullough A,. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005; 2: 658-667.
24. Kedia S, Zippe C, Agarwal A, Nelson D, Lakin M,. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer. Urology 1999; 54: 308-312.
25. Weber D, Bieri S, Kurtz J, Miralbell R,. Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer. J Clin Oncol 1999; 17: 3444-3449.
26. Zelefsky J, McKee A, Lee H, Leibel S,. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 1999; 53: 775-778.
27. Valicenti R, Choi E, Chen C, et al. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy. Urology 2001; 57: 769-773.
28. Teloken P, Parker M, Mohideen N, Mulhall J,. Predictors of response to sildenafil citrate following radiation therapy for prostate cancer. J Sex Med 2009; 6: 1135-1140.
29. Watkins-Bruner D, James J, Bryan C, et al. Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of the RTOG 0215. J Sex Med 2011; 8: 1228-1238.
30. Incrocci L, Koper P, Hop W, Slob A,. Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys 2001; 51: 1190-1195.
31. Incrocci L, Slagter C, Slob A, Hop W,. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis(R)) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: S38-39.
32. Harrington C, Campbell G, Wynne C, Atkinson C,. Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer. J Med Imaging Radiat Oncol 2010; 54: 224-228.
33. Rosen R, Riley A, Wagner G, Osterloh I, Kirkpatrick J, Mishra A,. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
34. Rosen R, Cappelleri J, Gendrano N,. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226-244.
35. Cappelleri J, Rosen R, Smith M, Mishra A, Osterloh I,. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999; 54: 346-351.
36. Rosen R, Cappelleri J, Smith M, Lipsky J, Pena B,. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326.
37. National Cancer Institute. Common Toxicity Criteria Manual. Common Toxicity Criteria, Version 20. 1999.
38. Department of Health and Ageing. The Australian Clinical Trial Handbook. Therapeutic Goods Administration, Canberra, Australia, 2006.
39. Zippe C, Pahlajani G,. Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy. Urol Clin North Am 2007; 34: 601-618.
40. User H, Hairston J, Zelner D, McKenna K, McVary K,. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175-1179.
41. Mulhall J, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371-1375.
42. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V,. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 1673-1676.
43. Munding M, Wessells H, Dalkin B,. Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 2001; 58: 567-569.
44. Montorsi F, Guazzoni G, Strambi L, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408-1410.
45. Schiff J, Bar-Chama N, Cesaretti J, Stock R,. Early Use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. BJU Int 2006; 98: 1255-1258.
46. Ohebshalom M, Parker M, Guhring P, Mulhall J,. The efficacy of sidenafil citrate following radiation therapy for prostate cancer: temporal considerations. J Urol 2005; 174: 258-262.
47. Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54: 924-931.
48. Al Shaiji T, Domes T, Brock G,. Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art. Can Urol Assoc J 2009; 3: 37-48.
49. Nandipati K, Raina R, Agarwal A, Zippe C,. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res 2006; 18: 446-451.
50. Yassin A, Saad F,. Favorable effects of early 'penile rehabilitation' following nerve sparing radical prostatectomy. J Sex Med 2006; 3 (Suppl 5): 407.
51. McMahon C, Samali R, Johnson H,. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol 1999; 162: 1992-1997.
52. Nehra A, Blute M, Barrett D, Moreland R,. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 2002; 14: S38-42.